Scientists develop one-product-fits-all immunotherapy for pancreatic cancer

Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the disease has already spread ...

Discovery reveals role of EGFR in resistance to KRAS inhibitors in pancreatic cancer

A study led by University of Cincinnati Cancer Center researchers sheds new light on how pancreatic cancer cells resist ...
Cancer Therapy Advisor

Excess Weight Linked to Increased Risk for Early-Onset Pancreatic Cancer

In this study, researchers evaluated the dose-response relationship between body mass index and the risk of developing pancreatic cancer by the age of 50 years.
ascopubs.org

Prognostic Validity of a Novel American Joint Committee on Cancer Staging Classification for Pancreatic Neuroendocrine Tumors

Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With ...